通过甲状腺癌的倾向性得分匹配进行比较分析:揭示多种恶性瘤的影响
Akram Al-Ibraheem1,2, Ahmed Saad Abdlkadir1, Dhuha Ali Al-Adhami1
1Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan.
Frontiers in endocrinology
|June 19, 2024
概括
甲状腺癌患者多重原发性瘤 (MPN) 与较差的生存率有关. 诸如诊断时年龄较大和家族病史等因素可能表明MPN风险较高.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 癌症流行病学 癌症流行病学
背景情况:
- 在全球范围内,甲状腺癌的发病率正在增加.
- 辐射暴露是已知的风险因素,但其他潜在的风险因素需要调查.
- 这项研究调查了与甲状腺癌相关的恶性瘤和单独与多重初级瘤 (MPN) 患者的存活率.
研究的目的:
- 为了探索与甲状腺癌相关的恶性瘤.
- 为了比较甲状腺癌患者单一瘤和多重原发性瘤 (MPN) 患者的生存率.
- 在甲状腺癌患者中确定与MPN相关的临床特征.
主要方法:
- 使用约旦侯赛因国王癌症中心 (KHCC) 数据进行的回顾性研究.
- 包括563名被诊断为甲状腺癌的患者,其中30名被确定为MPN.
- 1:3倾向性得分匹配分析包括90名患有单一甲状腺恶性瘤的患者.
主要成果:
- 血液和乳腺恶性瘤是常见的与甲状腺瘤同时发生的癌症.
- 患有MPN的患者在年龄较大时被诊断出癌症,BMI较高,铁血球蛋白抗体水平升高,癌症家族病史较强 (p < 0.05).
- 与单独瘤患者 (100%;p < 0.01) 相比,MPN患者的5年生存率 (87%) 显著降低,而无事件的5年生存率没有差异.
结论:
- 多重原发性瘤与甲状腺癌患者的生存结果发生显著改变有关.
- 诊断时的年龄较大,初始甲状腺球蛋白抗体水平升高,以及家族癌症史可能表明同步或超时瘤的风险增加.
- 这些发现强调了在治疗和跟踪甲状腺癌患者时考虑MPN的重要性.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177
Cancer Survival Analysis
342
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342


